Article Details
Retrieved on: 2025-06-15 22:37:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Piper Sandler upgraded Sutro Biopharma (STRO) to Overweight from Neutral with an unchanged price target of $2. Published first on TheFly – the ...
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here